In silico comparative analysis of HIV protease inhibitors effect on 2019-nCoV coronavirus 3CLpro
Open Access
- 3 July 2020
- journal article
- Published by Heighten Science Publications Corporation in Annals of Proteomics and Bioinformatics
- Vol. 4 (1), 012-014
- https://doi.org/10.29328/journal.apb.1001011
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic ReviewJournal of Clinical Medicine, 2020
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)Nature Reviews Drug Discovery, 2020
- Molecular mechanisms of coronavirus RNA capping and methylationVirologica Sinica, 2016
- Combination Therapy with Lopinavir/Ritonavir, Ribavirin and Interferon-α for Middle East Respiratory SyndromeAntiviral Therapy, 2015
- HIV protease inhibitors: a review of molecular selectivity and toxicityHIV/AIDS - Research and Palliative Care, 2015
- Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptorNature, 2013
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Review of Bats and SARSEmerging Infectious Diseases, 2006